Literature DB >> 17906627

The MAPK-activated kinase Rsk controls an acute Toll-like receptor signaling response in dendritic cells and is activated through two distinct pathways.

Rossana Zaru1, Natalia Ronkina, Matthias Gaestel, J Simon C Arthur, Colin Watts.   

Abstract

Most dendritic cell (DC) responses to Toll-like receptor (TLR) ligands depend on the activation of mitogen-activated protein kinases (MAPKs), but the contributions of the many MAPK-activated kinases (MKs) that act 'downstream' of the MAPKs Erk and p38 are not known. Here we sought to determine which MKs are required for acute TLR-driven, MAPK-dependent DC endocytic responses. Two specific and structurally different inhibitors of the MK Rsk suppressed TLR-induced endocytosis, thus defining in DCs a specific requirement for MKs in TLR responses. In addition, we identify in DCs a previously unknown configuration of the MAPK system whereby Rsk is activated not only by Erk but also by p38 through the intermediates MK2 and MK3. Thus, in DCs, p38 contributes to the activation of all known MK families.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17906627     DOI: 10.1038/ni1517

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  53 in total

1.  CD14 controls the LPS-induced endocytosis of Toll-like receptor 4.

Authors:  Ivan Zanoni; Renato Ostuni; Lorri R Marek; Simona Barresi; Roman Barbalat; Gregory M Barton; Francesca Granucci; Jonathan C Kagan
Journal:  Cell       Date:  2011-11-11       Impact factor: 41.582

2.  IL-3 Maintains Activation of the p90S6K/RPS6 Pathway and Increases Translation in Human Eosinophils.

Authors:  Stephane Esnault; Elizabeth A B Kelly; Zhong-Jian Shen; Mats W Johansson; James S Malter; Nizar N Jarjour
Journal:  J Immunol       Date:  2015-08-14       Impact factor: 5.422

3.  The kinase p38 alpha serves cell type-specific inflammatory functions in skin injury and coordinates pro- and anti-inflammatory gene expression.

Authors:  Chun Kim; Yasuyo Sano; Kristina Todorova; Bradley A Carlson; Luis Arpa; Antonio Celada; Toby Lawrence; Kinya Otsu; Janice L Brissette; J Simon C Arthur; Jin Mo Park
Journal:  Nat Immunol       Date:  2008-09       Impact factor: 25.606

Review 4.  The nuts and bolts of AGC protein kinases.

Authors:  Laura R Pearce; David Komander; Dario R Alessi
Journal:  Nat Rev Mol Cell Biol       Date:  2010-01       Impact factor: 94.444

5.  C-reactive protein induces TNF-α secretion by p38 MAPK-TLR4 signal pathway in rat vascular smooth muscle cells.

Authors:  Na Liu; Juntian Liu; Yuanyuan Ji; Peipei Lu; Chenjing Wang; Fang Guo
Journal:  Inflammation       Date:  2011-08       Impact factor: 4.092

6.  Alcohol intoxication following muscle contraction in mice decreases muscle protein synthesis but not mTOR signal transduction.

Authors:  Jennifer L Steiner; Charles H Lang
Journal:  Alcohol Clin Exp Res       Date:  2015-01       Impact factor: 3.455

Review 7.  Insights into phagocytosis-coupled activation of pattern recognition receptors and inflammasomes.

Authors:  Julien Moretti; J Magarian Blander
Journal:  Curr Opin Immunol       Date:  2013-12-05       Impact factor: 7.486

Review 8.  Toll-like receptor signaling in cell proliferation and survival.

Authors:  Xinyan Li; Song Jiang; Richard I Tapping
Journal:  Cytokine       Date:  2009-09-22       Impact factor: 3.861

9.  Mutation of the PDK1 PH domain inhibits protein kinase B/Akt, leading to small size and insulin resistance.

Authors:  Jose R Bayascas; Stephan Wullschleger; Kei Sakamoto; Juan M García-Martínez; Carol Clacher; David Komander; Daan M F van Aalten; Krishna M Boini; Florian Lang; Christopher Lipina; Lisa Logie; Calum Sutherland; John A Chudek; Janna A van Diepen; Peter J Voshol; John M Lucocq; Dario R Alessi
Journal:  Mol Cell Biol       Date:  2008-03-17       Impact factor: 4.272

Review 10.  Molecular control of steady-state dendritic cell maturation and immune homeostasis.

Authors:  Gianna Elena Hammer; Averil Ma
Journal:  Annu Rev Immunol       Date:  2013-01-17       Impact factor: 28.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.